anti cd105 Search Results


antihuman cd105 apc 23  (Miltenyi Biotec)
95
Miltenyi Biotec antihuman cd105 apc 23
Antihuman Cd105 Apc 23, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/CD105+Antibody%2C+anti-human/pmc05608703__41598_2017_12360_MOESM1_ESM-9-40-45
Average 95 stars, based on 1 article reviews
antihuman cd105 apc 23 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
cd105  (Elabscience Biotechnology)
94
Elabscience Biotechnology cd105
Fig. 1 Characterization of hUCMSCs. A Primary hUCMSCs were spindle-shaped under light microscopy. B Flow cytometry analysis showed that 98.5% of cells expressed CD29, 97.4% expressed CD44, 98.6% of cells expressed CD90, and 98.1% of cells expressed <t>CD105.</t> Meanwhile, only 0.48% and 0.28% expressed CD45 and CD34. C Lipid droplets were stained by oil red O after adipogenic differentiation induction of hUCMSCs. Mineralized nodules were stained by Alizarin Red after osteogenic differentiation induction of hUCMSCs. Acid mucopolysaccharide was stained by Alcian Blue after chondrogenic differentiation induction of hUCMSCs
Cd105, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/PE+Anti-Human+CD105+Antibody/pm37789395-60-26-28
Average 94 stars, based on 1 article reviews
cd105 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
cd105 fitc  (Miltenyi Biotec)
94
Miltenyi Biotec cd105 fitc
(a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
Cd105 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/CD105+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__06__25__733625-69-8-9
Average 94 stars, based on 1 article reviews
cd105 fitc - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
cd105  (Bio-Rad)
94
Bio-Rad cd105
(a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
Cd105, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/Mouse+anti+Human+CD105/10__62347_slash_uagf1249-73-9-23
Average 94 stars, based on 1 article reviews
cd105 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
mouse anti cd105  (Elabscience Biotechnology)
90
Elabscience Biotechnology mouse anti cd105
(a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
Mouse Anti Cd105, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/PE+Anti-Mouse+CD105+Antibody/pmc09235033-41-17-20
Average 90 stars, based on 1 article reviews
mouse anti cd105 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
cd105  (Biogems International)
93
Biogems International cd105
FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, <t>CD105,</t> and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.
Cd105, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/Anti-Human+CD105+(Endoglin)+PE/pm40536887-52-31-32
Average 93 stars, based on 1 article reviews
cd105 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
cd105  (Boster Bio)
93
Boster Bio cd105
FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, <t>CD105,</t> and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.
Cd105, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/Anti-Endoglin+%2F+CD105+Reference+Antibody/pm41844706-126-24-25
Average 93 stars, based on 1 article reviews
cd105 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
cd105  (Miltenyi Biotec)
93
Miltenyi Biotec cd105
FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, <t>CD105,</t> and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.
Cd105, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/CD105+Antibody%2C+anti-mouse/pm30537746-80-51-53
Average 93 stars, based on 1 article reviews
cd105 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
pe conjugated anti cd 105  (Miltenyi Biotec)
91
Miltenyi Biotec pe conjugated anti cd 105
FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, <t>CD105,</t> and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.
Pe Conjugated Anti Cd 105, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/CD105+Antibody%2C+anti-mouse%2C+REAfinity/pmc10202607-43-29-31
Average 91 stars, based on 1 article reviews
pe conjugated anti cd 105 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
cd45 apc  (Elabscience Biotechnology)
94
Elabscience Biotechnology cd45 apc
FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, <t>CD105,</t> and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.
Cd45 Apc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd105/FITC+Anti-Mouse+CD105+Antibody/pm41593745-63-18-27
Average 94 stars, based on 1 article reviews
cd45 apc - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 Characterization of hUCMSCs. A Primary hUCMSCs were spindle-shaped under light microscopy. B Flow cytometry analysis showed that 98.5% of cells expressed CD29, 97.4% expressed CD44, 98.6% of cells expressed CD90, and 98.1% of cells expressed CD105. Meanwhile, only 0.48% and 0.28% expressed CD45 and CD34. C Lipid droplets were stained by oil red O after adipogenic differentiation induction of hUCMSCs. Mineralized nodules were stained by Alizarin Red after osteogenic differentiation induction of hUCMSCs. Acid mucopolysaccharide was stained by Alcian Blue after chondrogenic differentiation induction of hUCMSCs

Journal: Journal of nanobiotechnology

Article Title: Cerium oxide nanoparticles-carrying human umbilical cord mesenchymal stem cells counteract oxidative damage and facilitate tendon regeneration.

doi: 10.1186/s12951-023-02125-5

Figure Lengend Snippet: Fig. 1 Characterization of hUCMSCs. A Primary hUCMSCs were spindle-shaped under light microscopy. B Flow cytometry analysis showed that 98.5% of cells expressed CD29, 97.4% expressed CD44, 98.6% of cells expressed CD90, and 98.1% of cells expressed CD105. Meanwhile, only 0.48% and 0.28% expressed CD45 and CD34. C Lipid droplets were stained by oil red O after adipogenic differentiation induction of hUCMSCs. Mineralized nodules were stained by Alizarin Red after osteogenic differentiation induction of hUCMSCs. Acid mucopolysaccharide was stained by Alcian Blue after chondrogenic differentiation induction of hUCMSCs

Article Snippet: Briefly, 107 hUCMSCs were subjected to analysis for surface markers CD34 (E-AB-F1143D, Elabscience), CD44 (E-AB-F1100D, Elabscience), CD45 (E-AB-F1137D, Elabscience), CD29 (E-AB-F1049D, Elabscience), CD90 (E-AB-F1167D, Elabscience), and CD105 (E-AB-F1310D, Elabscience) by flow cytometry following the manufacturer’s protocol.

Techniques: Light Microscopy, Flow Cytometry, Staining

(a) Immunofluorescence staining showing expression of Vimentin (green) and CD105 (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.

Journal: bioRxiv

Article Title: Human SHED-derived extracellular cues activate a specialized neuroprotective and regenerative program in developing retinal ganglion cells

doi: 10.64898/2026.06.25.733625

Figure Lengend Snippet: (a) Immunofluorescence staining showing expression of Vimentin (green) and CD105 (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.

Article Snippet: Antibodies against the following human antigens were used: CD105-FITC (Miltenyi Biotect, Bergisch Gladbach, Germany, cat# 130-112-327, 1:50), CD90-FITC (Miltenyi Biotec, cat# 130-114-901, 1:50), CD44-VioBlue (Miltenyi Biotec, cat# 130-113-906, 1:50), CD73-APC (Miltenyi Biotec, cat# 130-111-909, 1:50), MSC Phenotyping Cocktail-PE (CD34, CD14, CD19, CD45, Miltenyi Biotec cat# 130-125-285, dilution according to the manufacturer’s instructions).

Techniques: Immunofluorescence, Staining, Expressing, Immunostaining, Flow Cytometry, Derivative Assay

FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, CD105, and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.

Journal: Journal of cellular and molecular medicine

Article Title: Insights From Amniotic and Umbilical Cord Mesenchymal Stem Cells in Wound Healing.

doi: 10.1111/jcmm.70679

Figure Lengend Snippet: FIGURE 1 | Isolation and characterisation of UC-MSCs and A-MSCs. (A) Both UC-MSCs and A-MSCs exhibit a typical spindle-shaped morphol- ogy. Scale bar = 100 μm. (B) The proliferation of the two cells was evaluated by CCK8 assay. (C) These cells are positively stained for the common MSC-associated markers, CD73, CD90, CD105, and have no expression of haematopoietic markers CD45, CD34 and HLA-DR. (D) Following the cul- ture in a specific differentiation medium for 2–3 weeks, the isolated UC-MSCs and A-MSCs successfully differentiated into mesenchymal derivatives, including osteoblasts (Alizarin Red labeling), adipocytes (Oil Red O labeling) and chondrocytes (Alcian blue). Scale bar = 50 μm. (E) The transwell was adopted to evaluate the migration ability of the two types of cells. Scale bar = 50 μm. (F) The wound healing assays were further adopted for the migration ability of the cells. Scale bar = 100 μm.

Article Snippet: Additionally, phenotypic characteristics of UC- MSCs and A- MSCs at passage 3 were analysed by flow cytometry using antibodies against CD14 (BD Biosciences; 555397), CD34 (BD Biosciences; 555822), CD73 (BioLegend; 344004), CD105 (BioGems; 17111- 60), HLA- DR (BD Biosciences; 555811) and CD90 (BioLegend; 328110), with isotype- matched antibodies (PE, BD Biosciences; 555749; FITC, BD Biosciences; 555573) serving as a negative control.

Techniques: Isolation, CCK-8 Assay, Staining, Expressing, Labeling, Migration